Mental health may play a role in dialysis patients' survival

April 5, 2012

Dialysis patients whose mental health deteriorates over time have an increased risk of developing heart problems and dying prematurely, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society Nephrology (CJASN). Additional research should investigate whether caring for kidney disease patients' mental health may help prevent heart complications and even death.

Research indicates that can affect heart health. Because heart disease is the leading cause of death in patients, Ea Wha Kang, MD, PhD (Ilsan Hospital, in Gyeonggi-do, Korea), Mark Unruh, MD (University of Pittsburgh Medical Center) and their colleagues looked to see how changes in dialysis patients' mental health relate to their heart health and longevity.

The study included 1,846 dialysis patients who were enrolled in a clinical trial called the Hemodialysis Study. The investigators assessed patients' mental health at the start of the study and each year for three years through surveys and questionnaires.

Patients who had lower mental health scores over time tended to die or be hospitalized for heart problems sooner than patients with steady or rising scores. Specifically, their survival time decreased by 5.8% and their time to first hospitalization due to heart problems decreased by 7.6%.

"Our results emphasize the link between mind and body in patients with chronic illness and underscore the importance of attention to mental health for preventing cardiac complications and even death in ," said Dr. Kang.

Explore further: Similar blood pressure drugs could have different impacts on dialysis patients' heart health

More information: The article, entitled "The Association of Mental Health over Time with Cardiac Outcomes in HEMO Study Patients," will appear online on April 5, 2012, doi:10.2215/CJN.06730711

Related Stories

Recommended for you

Ebola virus mutations may help it evade drug treatment

September 11, 2015

Genetic mutations called "escape variants" in the deadly Ebola virus appear to block the ability of antibody-based treatments to ward off infection, according to a team of U.S. Army scientists and collaborators. Their findings, ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.